165 related articles for article (PubMed ID: 21508173)
21. Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines.
Arrington J; Braun RP; Dong L; Fuller DH; Macklin MD; Umlauf SW; Wagner SJ; Wu MS; Payne LG; Haynes JR
J Virol; 2002 May; 76(9):4536-46. PubMed ID: 11932419
[TBL] [Abstract][Full Text] [Related]
22. Recombinant rubella vectors elicit SIV Gag-specific T cell responses with cytotoxic potential in rhesus macaques.
Rosati M; Alicea C; Kulkarni V; Virnik K; Hockenbury M; Sardesai NY; Pavlakis GN; Valentin A; Berkower I; Felber BK
Vaccine; 2015 Apr; 33(18):2167-74. PubMed ID: 25802183
[TBL] [Abstract][Full Text] [Related]
23. Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice.
Moore AC; Kong WP; Chakrabarti BK; Nabel GJ
J Virol; 2002 Jan; 76(1):243-50. PubMed ID: 11739689
[TBL] [Abstract][Full Text] [Related]
24. Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-gamma, or IL-4 gene adjuvants.
Kim JJ; Yang JS; Manson KH; Weiner DB
Vaccine; 2001 Mar; 19(17-19):2496-505. PubMed ID: 11257383
[TBL] [Abstract][Full Text] [Related]
25. DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV.
Hu X; Valentin A; Dayton F; Kulkarni V; Alicea C; Rosati M; Chowdhury B; Gautam R; Broderick KE; Sardesai NY; Martin MA; Mullins JI; Pavlakis GN; Felber BK
J Immunol; 2016 Nov; 197(10):3999-4013. PubMed ID: 27733554
[TBL] [Abstract][Full Text] [Related]
26. Intravenous inoculation of replication-deficient recombinant vaccinia virus DIs expressing simian immunodeficiency virus gag controls highly pathogenic simian-human immunodeficiency virus in monkeys.
Izumi Y; Ami Y; Matsuo K; Someya K; Sata T; Yamamoto N; Honda M
J Virol; 2003 Dec; 77(24):13248-56. PubMed ID: 14645581
[TBL] [Abstract][Full Text] [Related]
27. A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity.
Someya K; Xin KQ; Matsuo K; Okuda K; Yamamoto N; Honda M
J Virol; 2004 Sep; 78(18):9842-53. PubMed ID: 15331719
[TBL] [Abstract][Full Text] [Related]
28. Studies on GM-CSF DNA as an adjuvant for neutralizing Ab elicited by a DNA/MVA immunodeficiency virus vaccine.
Robinson HL; Montefiori DC; Villinger F; Robinson JE; Sharma S; Wyatt LS; Earl PL; McClure HM; Moss B; Amara RR
Virology; 2006 Sep; 352(2):285-94. PubMed ID: 16740288
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques.
McDermott AB; O'Connor DH; Fuenger S; Piaskowski S; Martin S; Loffredo J; Reynolds M; Reed J; Furlott J; Jacoby T; Riek C; Dodds E; Krebs K; Davies ME; Schleif WA; Casimiro DR; Shiver JW; Watkins DI
J Virol; 2005 Dec; 79(24):15556-66. PubMed ID: 16306626
[TBL] [Abstract][Full Text] [Related]
30. Antibodies to gp120 and PD-1 expression on virus-specific CD8+ T cells in protection from simian AIDS.
Vaccari M; Halwani R; Patterson LJ; Boasso A; Beal J; Tryniszewska E; Hryniewicz A; Venzon D; Haddad EK; El-Far M; Rosati M; Pavlakis GN; Felber BK; Al-Muhsen S; Robert-Guroff M; Sekaly RP; Franchini G
J Virol; 2013 Mar; 87(6):3526-37. PubMed ID: 23325679
[TBL] [Abstract][Full Text] [Related]
31. Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine.
Qureshi H; Ma ZM; Huang Y; Hodge G; Thomas MA; DiPasquale J; DeSilva V; Fritts L; Bett AJ; Casimiro DR; Shiver JW; Robert-Guroff M; Robertson MN; McChesney MB; Gilbert PB; Miller CJ
J Virol; 2012 Feb; 86(4):2239-50. PubMed ID: 22156519
[TBL] [Abstract][Full Text] [Related]
32. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
[TBL] [Abstract][Full Text] [Related]
33. Co-administration of plasmid-encoded granulocyte-macrophage colony-stimulating factor increases human immunodeficiency virus-1 DNA vaccine-induced polyfunctional CD4+ T-cell responses.
Santana VC; Almeida RR; Ribeiro SP; Ferreira LC; Kalil J; Rosa DS; Cunha-Neto E
Mem Inst Oswaldo Cruz; 2015 Dec; 110(8):1010-6. PubMed ID: 26602876
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection.
Zheng Q; Fan D; Gao N; Chen H; Wang J; Ming Y; Li J; An J
Vaccine; 2011 Jan; 29(4):763-71. PubMed ID: 21095256
[TBL] [Abstract][Full Text] [Related]
35. Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine.
Schwerdtfeger M; Andersson AC; Neukirch L; Holst PJ
J Transl Med; 2019 May; 17(1):175. PubMed ID: 31126293
[TBL] [Abstract][Full Text] [Related]
36. Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles.
Bridge SH; Sharpe SA; Dennis MJ; Dowall SD; Getty B; Anson DS; Skinner MA; Stewart JP; Blanchard TJ
Virol J; 2011 Sep; 8():429. PubMed ID: 21899739
[TBL] [Abstract][Full Text] [Related]
37. Immunogenicity of DNA vaccines that direct the coincident expression of the 120 kDa glycoprotein of human immunodeficiency virus and the catalytic domain of cholera toxin.
Bagley KC; Shata MT; Onyabe DY; DeVico AL; Fouts TR; Lewis GK; Hone DM
Vaccine; 2003 Jul; 21(23):3335-41. PubMed ID: 12804865
[TBL] [Abstract][Full Text] [Related]
38. Control of Heterologous Simian Immunodeficiency Virus SIV
Singh S; RamÃrez-Salazar EG; Doueiri R; Valentin A; Rosati M; Hu X; Keele BF; Shen X; Tomaras GD; Ferrari G; LaBranche C; Montefiori DC; Das J; Alter G; Trinh HV; Hamlin C; Rao M; Dayton F; Bear J; Chowdhury B; Alicea C; Lifson JD; Broderick KE; Sardesai NY; Sivananthan SJ; Fox CB; Reed SG; Venzon DJ; Hirsch VM; Pavlakis GN; Felber BK
J Virol; 2018 Aug; 92(15):. PubMed ID: 29793957
[TBL] [Abstract][Full Text] [Related]
39. Intranasal inoculate of influenza virus vaccine against lethal virus challenge.
Fan X; Su Q; Qiu F; Yi Y; Shen L; Jia Z; Liang P; Zou Y; Bi S
Vaccine; 2018 Jul; 36(29):4354-4361. PubMed ID: 29880240
[TBL] [Abstract][Full Text] [Related]
40. Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 Gag.
Qiu JT; Chang TC; Lin CT; Chen YM; Li FQ; Soong YK; Lai CH
Vaccine; 2007 Jan; 25(2):253-63. PubMed ID: 16971027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
